SCINAI IMMUNOTHERAPEUTICS LT (SCNI) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:SCNI • US09073Q3039

1.01 USD
+0.02 (+2.02%)
At close: Feb 3, 2026
1.01 USD
0 (0%)
Pre-Market: 2/4/2026, 4:01:00 AM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to SCNI. The Buy consensus is the weighted average rating of the current analysts ratings.

  • SCNI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SCNI.
  • In the previous month the buy percentage consensus was at a similar level.
  • SCNI was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

SCNI Historical Analyst RatingsSCNI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -21 -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6
SCNI Current Analyst RatingSCNI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades

SCINAI IMMUNOTHERAPEUTICS LT / SCNI FAQ

Can you provide the consensus rating for SCINAI IMMUNOTHERAPEUTICS LT stock?

The consensus rating for SCINAI IMMUNOTHERAPEUTICS LT (SCNI) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts have analysed SCINAI IMMUNOTHERAPEUTICS LT (SCNI)?

The number of analysts covering SCINAI IMMUNOTHERAPEUTICS LT (SCNI) is 7.